Screening for vancomycin intermediate - Resistant Staphylococcus aureus among clinical isolates of MRSA [9]

Indian Journal of Medical Microbiology

Volumn 25, Issue 1, 2007, Pages 79-80

  Sonavane, A ^a   De, A ^a   Mathur, M ^a  

^a LOKMANYA TILAK MUNICIPAL MEDICAL COLLEGE AND GENERAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM COLONY; BACTERIUM DETECTION; BACTERIUM ISOLATE; DRUG MONITORING; DRUG SENSITIVITY; HOSPITAL; HUMAN; INDIA; INTENSIVE CARE UNIT; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; MORTALITY; NONHUMAN; SHORT COURSE THERAPY; STAPHYLOCOCCUS AUREUS;

EID: 33947526604     PISSN: 02550857     EISSN: 02550857     Source Type: Journal    
DOI: 10.4103/0255-0857.31078     Document Type: Letter

References (5)

1. CDC. Reduced susceptibility of Staphylococcus aureus to vancomycin - Japan 1996. MMWR 1997;46:624-6.
2. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S, et al. Dissemination in Japanese hospitals of strains of Satphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670-3.
3. Assadullah S, Kakru DK, Thoker MA, Bhat PA, Hussain N, Shah A. Emergence of low level vancomycin resistance in MRSA. Indian J Med Microbiol 2003;21:196-8.
4. NCCLS. Performance Standards for the Antimicrobial susceptibility Testing: Eleventh Informational Supplement. NCCLS document M100-S11 (ISBN 1-56238 - 426 - 0). Wayne, Pennsylyania 19087-1898. USA 2001. Table 2C, pp 49, 50, 92.
5. Geisel R, Schimtz FJ, Thomas L, Berns G, Zetsche O, Ulrich B, et al. Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf area. J Antimicrob Chemother 1999;43:846-8.